Mesoporous bioactive nanocarriers in electrospun biopolymer fibrous scaffolds designed for sequential drug delivery
- 4 December 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (9) , 4444-4452
Abstract
Here we communicate a novel design to deliver multiple drugs from scaffolds which have special therapeutic efficacy for the repair and regeneration of hard tissues. A sequential release of multiple drugs (a rapid release of drug 1 accompanied by a slow release of drug 2) was enabled by pre-loading drug 2 within mesoporous bioactive glass nanospheres (mBGn) which were added up to 30% to a polymer (polycaprolactone–gelatin) fiber matrix that has also encapsulated drug 1. In particular, excellent bioactive properties of mBGn, i.e., induction of bone mineral-like apatite formation and release of therapeutic ions (calcium and silicon) potentiate the usefulness of the mBGn-added scaffolds for bone regeneration. Proof-of-concept study utilizing two model drugs within the mBGn-added fiber (procaine hydrochloride (PCH) in mBGn and tetracycline hydrochloride (TCH) in nanofiber) demonstrated a typical sequential release pattern of the drugs, i.e., a rapid release of TCH within 24 h while a sustainable and long-term release of PCH over weeks to a month. Although biological efficacy of the drug-delivering scaffolds warrants further study, this finding suggests the mBGn-added polymer fiber may be a potential therapeutic matrix for bone regeneration.Keywords
This publication has 28 references indexed in Scilit:
- Basic fibroblast growth factor-loaded, mineralized biopolymer-nanofiber scaffold improves adhesion and proliferation of rat mesenchymal stem cellsBiotechnology Letters, 2013
- Delivery of definable number of drug or growth factor loaded poly(dl-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregatesJournal of Controlled Release, 2013
- Combined Angiogenic and Osteogenic Factor Delivery for Bone Regenerative EngineeringCurrent Pharmaceutical Design, 2013
- Electrospun matrices for localised controlled drug delivery: release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate)Drug Delivery and Translational Research, 2012
- Nanofiber-based delivery of bioactive agents and stem cells to bone sitesAdvanced Drug Delivery Reviews, 2012
- A short review: Recent advances in electrospinning for bone tissue regenerationJournal of Tissue Engineering, 2012
- Slow-Release Human Recombinant Bone Morphogenetic Protein-2 Embedded Within Electrospun Scaffolds for Regeneration of Bone Defect: In Vitro and In Vivo EvaluationTissue Engineering Part A, 2011
- Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionalityBiomaterials, 2010
- Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshesJournal of Controlled Release, 2010
- Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsJournal of The Royal Society Interface, 2009